1. Epigenetic Silencing of CHOP Expression by the Histone Methyltransferase EHMT1 Regulates Apoptosis in Colorectal Cancer Cells
   Kwangho Kim et al, 2022, Molecules and Cells CrossRef
2. Epigenetic priming by EHMT1/EHMT2 in acute lymphoblastic leukemia induces TP53 and TP73 overexpression and promotes cell death
   Amandda Évelin Silva-Carvalho et al, 2020, Toxicology in Vitro CrossRef
3. Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma
   Sara Tahbazzadeh Moghaddam et al, 2023, Exploration of Targeted Anti-tumor Therapy CrossRef
4. Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes
   Nair Lopes et al, 2020, International Journal of Molecular Sciences CrossRef
5. EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms
   Alamelu Nachiyappan et al, 2022, The FEBS Journal CrossRef
6. EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression
   Jinkwon Lee et al, 2021, Molecular Oncology CrossRef
7. GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms
   Amandda Évelin Silva-Carvalho et al, 2024, Cancer Cell International CrossRef
8. EHMT2 inhibitor BIX-01294 induces apoptosis through PMAIP1-USP9X-MCL1 axis in human bladder cancer cells
   Jing Cui et al, 2015, Cancer Cell International CrossRef
9. G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death
   Eva De Smedt et al, 2021, Blood Advances CrossRef
10. Molecular and functional anticancer effects of GLP/G9a inhibition by UNC0646 in MeWo melanoma cells
    Luma Dayane de Carvalho Filiú-Braga et al, 2024, Heliyon CrossRef
11. Histone methyl transferases: A class of epigenetic opportunities to counter uncontrolled cell proliferation
    Pankaj Kumar Singh, 2019, European Journal of Medicinal Chemistry CrossRef
12. Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2
    Gareth Ang et al, 2022, Cancers CrossRef
13. Epigenetics in Esophageal Cancer: From Mechanisms to Therapeutics
    Long Liao et al, 2020, Small Methods CrossRef
14. Genomic and Epigenomic Alterations in Cancer
    Balabhadrapatruni V.S.K. Chakravarthi et al, 2016, The American Journal of Pathology CrossRef
15. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations
    Jean-François Spinella et al, 2016, Oncotarget CrossRef